Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083

• by Hannah P Moore, Jessica M Fogel, Mark A Marzinke, Elias K Halvas, Urvi M Parikh, John W Mellors, Kerri J Penrose, Michael Seisa, Christos Petropoulos, Amelia L Price, Amber Moser, Zhe Wang, Marybeth McCauley, Javier Valencia-Huamaní, Alex R Rinehart, James F Rooney, Lydia Soto-Torres, Beatriz Grinsztejn, Raphael J Landovitz, Susan H Eshleman

• October 15, 2025

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

• by Kerri Miller

• April 6, 2026

• 2 min

Expert panel endorse individualized beta-lactam dosing for acutely ill patients

International guidance supports concentration-guided dosing for selected acutely ill patients, with clinical cure showing the clearest benefit.

• by Doug Brunk

• August 17, 2026

• 7 min

CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria

Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms

• April 2, 2026

• 2 min